机构名称：
¥ 1.0
Features n % Median Mean Standard deviation Chemotherapy cycles 3439 100 General Cancer type Breast cancer 1315 38 Lung cancer 890 26 Colorectal cancer 1159 34 Other cancers 75 2 Stage 1 to 3 1927 4 1512 Involved systems number* 0 0.8 1.1 Gender Female 1811 53 Male 1628 47 Age 55 55.1 11.4 ECOG performance status 1 0.7 0.7 Coronary disease No 3133 91 Yes 306 9慢性阻塞性肺疾病（冷）否3252 95是187 5放疗3372 98在3372 98之前没有接受67 2先前的化疗NO 1922 56是1517 44治疗治疗方法作为住院NO 3240 94是3240 94是3240 94 YES 199 6 CSF YES 199 6 CSF否2543 74 YES 896 26 26 26 26 26 NO 311 NO 311 NO 311 11 11 1117剂量重新降差 neutropenia No 3211 93 Yes 228 7 Febrile neutropenia after chemotherapy No 3306 96 Yes 133 4 Drug number** 1 336 10 2 1644 48 3 1076 31 4 382 11 5 1 0 Regimen risk*** 1 938 27 2 2157 63 3 344 10 Cycle no on current protocol 3 2.8 1.4 Laboratory LDH (IU/ml) 343 370 235 ALT （IU/mL）18 22 20 20肌酐（mg/dl）0.71 0.76 0.22淋巴细胞计数（x1000/mm3）1.7 1.7 1.9 1.3白蛋白（mg/dl）4.2 4.2 4.2 0.4
平衡的装袋分类器机器学习模型 -
主要关键词
相关文件推荐
